Mirage News
Non-invasive treatment for liver tumours recognised through the UK’s Innovative Devices Access Pathway (IDAP) MINNEAPOLIS–BUSINESS WIRE– [HistoSonics], announced today that its Edison Histotripsy System for the non-invasive destruction of liver tumours has been granted controlled early limited market access in Great Britain under a Unmet Clinical Need Authorisation (UCNA). This designation, available through the UK’s
Read More
HistoSonics’ Edison System Secures UK Market Access | Mirage News
Mirage News
14:19
Non-invasive treatment for liver tumours recognised through the UK’s Innovative Devices Access Pathway (IDAP) MINNEAPOLIS–BUSINESS WIRE– [HistoSonics], announced today that its Edison Histotripsy System for the non-invasive destruction of liver tumours has been granted controlled early limited market access in Great Britain under a Unmet Clinical Need Authorisation (UCNA). This designation, available through the UK’s
